explor
best
primeboost
regimen
evalu
tcellular
respons
memori
hcv
construct
two
dna
vaccin
candid
two
recombin
virus
assess
immun
respons
differ
primeboost
pattern
balbc
mice
boost
immun
respons
hcv
dna
vaccin
prime
significantli
invert
termin
repeat
sequenc
harbor
dna
construct
best
prime
agent
studi
studi
provid
new
inform
primeboost
regimen
longterm
tcell
respons
hcv
vaccin
develop
certain
infect
tcell
central
acquir
immun
studi
shown
control
acut
hcv
infect
associ
vigor
broadli
direct
sustain
activ
hcvspecif
tcell
thu
engin
effici
adapt
immun
respons
especi
tcell
respons
goal
hcv
vaccin
strategi
dna
immun
use
induc
either
humor
cellular
immun
respons
variou
viral
bacteri
parasit
pathogen
immun
respons
induc
dna
immun
enhanc
modul
molecular
adjuv
plasmid
design
strategi
choic
antigen
multipl
antigen
tcell
epitop
adjust
method
locat
immun
vaccin
regimen
mani
vaccin
enhanc
combin
dna
vaccin
primeboost
regimen
boost
vaccin
often
recombin
viral
vector
purifi
protein
subunit
vaccin
strategi
involv
primari
vaccin
dna
vaccin
follow
boost
recombin
viru
vector
encod
immunogen
emerg
favor
approach
gener
protect
tcell
respons
mani
diseas
includ
hiv
malaria
cancer
pvrc
vector
use
dna
vaccin
develop
sarscov
highli
pathogen
avian
influenza
viru
viru
infect
elicit
much
stronger
immun
respons
compar
regular
dna
vaccin
vector
pcdna
seri
studi
shown
invert
termin
repeat
itr
cisact
element
requir
packag
integr
replic
flank
adenoassoci
viru
aav
genom
aav
may
strengthen
immun
dna
vaccin
meanwhil
dna
immun
boost
differ
viral
vector
protein
popular
vector
deriv
adenoviru
poxviru
studi
construct
plasmid
plasmid
encod
hcv
core
c
envelop
glycoprotein
also
construct
two
recombin
virus
recombin
vaccinia
tiantan
strain
recombin
adenoassoci
viru
similarli
encod
hcv
optim
primeboost
regimen
evalu
balbc
mice
region
hcv
aa
ncbi
access
insert
pvrc
paav
vector
construct
prime
dna
vaccin
candid
fig
origin
ttv
strain
dualpromot
insert
vector
deriv
lab
hcv
gene
aa
genotyp
insert
smai
site
vector
rttv
produc
transfect
cef
cell
infect
ttv
design
fig
gener
hcv
cdna
insert
neo
vector
fig
largescal
raav
product
purif
describ
previous
viral
titer
determin
dot
blot
dna
analysi
titer
given
vector
genom
vg
per
millilit
nine
group
femal
balbc
mice
week
old
immun
describ
tabl
anim
care
use
committe
china
cdc
approv
protocol
anim
experi
synthet
peptid
repres
hcv
aa
genotyp
mixtur
four
synthet
hcv
peptid
yevrnvsgiyhvtndcsnss
pgcvpcvregnssrcwvalt
regnssrcwvaltptlaarnati
prryetiqdcncsiypg
repres
linear
conserv
bcell
epitop
among
hcv
genotyp
coat
onto
enzymelink
immunosorb
assay
elisa
plate
assess
antibodi
respons
igg
titer
express
od
valu
measur
nm
quantif
hcvspecif
secret
cell
calcul
via
elispot
assay
mixtur
ctl
peptid
brestrict
new
england
biolab
ipswich
use
stimul
ghrmawdm
aa
sgpsqkiqlv
aa
ppqanwfgctwmnstgftkt
aa
rlwhypcti
aa
human
immunodefici
viru
peptid
riqrgpgrafvtigk
use
control
elispot
kit
purchas
bd
pharmingen
san
diego
ca
result
present
mean
elispot
posit
cellsmillion
cell
sd
group
signific
differ
experiment
control
group
evalu
use
twotail
fisher
exact
test
releas
spss
inc
chicago
il
differ
consid
signific
p
plasmid
transfect
cell
express
evalu
h
immunocellular
stain
western
blot
analysi
similarli
infect
cell
also
evalu
approach
four
construct
express
hcv
protein
well
data
show
optim
primeboost
regimen
seri
primeboost
regim
perform
balbc
mice
list
tabl
sera
immun
mice
sampl
pool
week
test
via
elisa
antibodi
respons
hcv
structur
protein
shown
fig
strongest
humor
respons
induc
regimen
consist
prime
boost
third
group
titer
regimen
dilut
antibodi
titer
remain
high
dilut
second
best
humor
respons
induc
regimen
consist
prime
boost
second
group
titer
dilut
dilut
third
strongest
humor
respons
induc
regimen
consist
prime
boost
also
third
group
titer
dilut
decreas
background
level
dilut
remain
regimen
rais
suffici
humor
respons
studi
data
suggest
plasmid
best
choic
prime
best
choic
boost
although
alon
could
induc
high
enough
humor
respons
time
point
blood
tabl
immun
strategi
immun
strategi
primeboost
regimen
divid
group
subgroup
micesubgroup
plasmid
dna
prime
inocul
week
dose
g
follow
recombin
viru
boost
week
pfu
vector
genom
vg
respect
sampl
taken
may
even
boost
humor
respons
fairli
high
level
fig
evalu
durat
tcell
respons
induc
primeboost
regimen
elispot
assay
perform
week
primari
inject
week
last
boost
meanwhil
capac
viral
vector
inject
recal
memori
respons
explor
via
assay
week
last
prime
dna
vaccin
number
tcell
determin
count
spotform
cell
sfc
mice
immun
prime
boost
regimen
tcell
fig
similarli
mice
immun
prime
boost
regimen
second
highest
number
tcell
fig
unlik
antibodi
respons
hcv
sfc
mice
inject
similar
control
group
fig
result
suggest
prime
boost
best
regimen
increas
robust
longterm
cellular
immun
respons
furthermor
studi
reveal
better
boost
method
induc
humor
cellular
immun
respons
induc
strong
longterm
protect
tcell
respons
prime
host
immun
system
critic
optim
vaccin
candid
primeboost
regim
also
import
studi
evalu
immun
respons
sever
vaccin
candid
explor
regimen
may
induc
effect
longterm
tcell
respons
hcv
envelop
protein
balbc
mice
result
demonstr
prime
follow
boost
induc
strong
longterm
tcell
respons
previou
studi
found
dna
vaccin
contain
itr
aav
increas
immun
hiv
optim
vaccin
construct
itr
sequenc
contain
itr
sequenc
result
indic
better
prime
candid
suggest
itr
improv
extend
tcell
respons
hcv
recombin
vaccinia
virus
rvv
gener
earli
shown
capabl
induc
protect
tcell
respons
small
anim
meanwhil
rvv
mani
advantag
immun
select
highli
replic
rttv
boost
vaccin
sinc
might
induc
longlast
immun
respons
via
singl
dose
safeti
well
document
larg
popul
compar
boost
elicit
much
lower
tcell
respons
consist
recent
report
aav
may
impair
tcell
respons
certain
situat
durat
tcell
respons
assess
sever
studi
dnamva
immun
regim
small
anim
complet
protect
month
prime
report
adenovirusvaccinia
immun
regim
plasmodium
yoelii
model
better
immunogen
protect
observ
increas
interv
prime
boost
week
studi
durabl
tcell
respons
differ
primeboost
regim
would
valuabl
result
show
prime
follow
boost
might
elicit
sustain
potent
tcell
respons
mice
even
primingboost
interv
long
week
current
hcv
vaccin
develop
focus
mainli
strength
crossprotect
longterm
assess
tcell
respons
limit
although
assess
suffici
comprehens
data
provid
inform
longterm
tcell
respons
hcv
balbc
mice
week
boost
